Clinical utility of the neurological examination in psychoses

Psychiatric Annals

Volumn 33, Issue 3, 2003, Pages 195-200

  Sanders, Richard D ^a,c   Keshavan, Matcheri S ^b   Goldstein, Gerald ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

AKATHISIA; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE MARKER; DYSTONIA; HIGH RISK PATIENT; HUMAN; MEASUREMENT; MEDICAL INFORMATICS; MENTAL PATIENT; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGY; OUTCOMES RESEARCH; PREDICTION; PSYCHOLOGIC TEST; PSYCHOSIS; REVIEW; RIGIDITY; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SCREENING TEST; SIDE EFFECT; SYMPTOM; TASK PERFORMANCE;

EID: 2042439075     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-20030301-08     Document Type: Review

References (50)

1. Heinrichs DW, Buchanan RW. Significance and meaning of neurological signs in schizophrenia. Am J Psychiatry. 1988;145:11-18.
2. Sanders RD, Keshavan MS. The neurological examination in adult psychiatry: from soft signs to hard science. J Neuropsychiatry Clin Neurosci. 1998;10:395-404.
3. Dazzan P, Murray RM. Neurological soft signs in first-episode psychosis: a systematic review. Br J Psychiatry Suppl. 2002;43:s50-57.
4. McGee S. Evidence-Based Physical Diagnosis. Philadelphia, PA: Saunders; 2001.
5. Sanders RD, Keshavan MS. Physical and neurologic examinations in neuropsychiatry. Seminars in Clinical Neuropsychiatry. 2002;7:18-29.
6. Mohr F, Hubmann W, Cohen R, et al. Neurological soft signs in schizophrenia: assessment and correlates. Eur Arch Clin Neurosci. 1996;246:240-248.
7. Arango C, Bartko JJ, Gold JM, et al. Prediction of neuropsychological performance by neurological signs in schizophrenia. Am J Psychiatry. 1999;156:1349-1357.
8. Sanders RD, Shuepbach D, Keshavan MS, et al. Neurologic exam abnormalities and neuropsychological performance in neuroleptic-naïve psychosis. J Neuropsychiatry Clin Neurosci. In press.
9. Jenkyn LR, Walsh DB, Culver CM, et al. Clinical signs of diffuse cerebral dysfunction. J Neurol Neurosurg Psychiatry. 1977;40:956-966.
10. Patten SB, Lamarre CJ. The face-hand test: a useful addition to the psychiatric physical examination. Psychiatr J Univ Ott. 1989;14:554-556.
11. Kinney DK, Yurgelun-Todd DA, Woods BT. Neurological hard signs in schizophrenia and major mood disorders. J Nerv Ment Dis. 1993;181:202-204.
12. Schwartz F, Carr A, Munich R, et al. Voluntary motor performance in psychotic disorders: a replication study. Psychol Rep. 1990;66:1223-1234.
13. Walker E. Attentional and neuromotor functions of schizophrenics, schizoaffectives, and patients with other affective disorders. Arch Gen Psychiatry. 1981;38:1355-1358.
14. Boks MPM, Russo S, Knegtering R, et al. The specificity of neurological signs in schizophrenia: a review. Schizophr Res. 2000; 43:109-116.
15. Buchanan RW, Heinrichs DW. The neurological evaluation scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res. 1989;27:335-350.
16. Keshavan MS, Sanders RD, Perez G, et al. Diagnostic specificity and neuroanatomical correlates of neurologic abnormalities in first-episode psychoses. Am J Psychiatry. In press.
17. Goldstein G, Allen DN, Sanders RD. Sensory-perceptual dysfunction in patients with schizophrenia and comorbid alcoholism. J Clin Exp Neuropsychol. In press.
18. Allen DN, Goldstein G, Forman SD, Keshavan MS, Van Kammen DP, Sanders RD. Neurologic examination abnormalities in schizophrenia with and without a history of alcoholism. Neuropsychiatry Neuropsychol Behav Neurol. 2000;13:184-187.
19. Allen DN, Goldstein G, Aldarondo F. Neurocognitive dysfunction in patients diagnosed with schizophrenia and alcoholism. Neuropsychology. 1999;13:62-68.
20. Erlenmeyer-Kimling L. Neurobehavioral deficits in offspring of schizophrenic parents: liability indicators and predictors of illness. Am J Med Genet. 2000;97:65-71.
21. Hans SL, Marcus J, Nuechterlein KH, et al. Neurobehavioral deficits at adolescence in children at risk for schizophrenia. Am J Psychiatry. 1999;56:741-748.
22. Egan MF, Hyde TM, Bonomo JB, et al. Relative risk of neurological signs in siblings of patients with schizophrenia. Am J Psychiatry. 2001;158:1827-1834.
23. Rosso IM, Bearden CE, Hollister JM, et al. Childhood neuromotor dysfunction in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophr Bull. 2000;26:367-378.
24. Erlenmeyer-Kimling L, Rock D, Roberts SA, et al. Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. Am J Psychiatry. 2000;157:1416-1422.
25. Jones P, Rodgers B, Murray R, et al. Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet. 1994;344:1398-1402.
26. Neumann CS, Walker EF. Childhood neuromotor soft signs, behavior problems, and adult psychopathology. Advances in Clinical Child Psychology. 1996;18:173-203.
27. Prager S, Jeste DV. Sensory impairment in late-life schizophrenia. Schizophr Bull. 1993;19:755-772.
28. David AS, Maimberg A, Lewis G, et al. Are there neurological and sensory risk factors for schizophrenia? Schizophr Res. 1995;14: 247-251.
29. Smith RC, Kadewari RP. Neurological soft signs and response to risperidone in chronic schizophrenia. Biol Psychiatry. 1996;40:1056-1059.
30. Meltzer HY. Predictors of response to clozapine. Psychiatric Annals. 1996;26:385-389.
31. Wirshing DA, Marshall BD, Green MF, et al. Risperidone in treatment-refractory schizophrenia. Am J Psychiatry. 1999;156:1374-1379.
32. Weaver LA, Brooks GW. The prediction of release from a mental hospital from psychomotor test performance. J Gen Psychol. 1967;76:207-229.
33. Johnstone EC, Macmillan JF, Frith CD, et al. Further investigation of the predictors of outcome following first schizophrenic episodes. Br J Psychiatry. 1990;157:182-189.
34. Perlick D, Mattis S, Stastny P, Teresi J. Neuropsychological discriminators of long-term inpatient or outpatient status in chronic schizophrenia. J Neuropsychiatry Clin Neurosci. 1992;4:428-434.
35. Smith RC, Kadewari RP, Rosenberger JR, et al. Nonresponding schizophrenia: differentiation by neurological soft signs and neuropsychological tests. Schizophr Bull. 1999;25:813-825.
36. Cheung P, Schweitzer I. Correlates of aggressive behavior in schizophrenia: an overview. Aust N Z J Psychiatry. 1998;32:400-409.
37. Krakowski MI, Czobor P, Chou JC. Course of violence in patients with schizophrenia: relationship to clinical symptoms. Schizophr Bull. 1999;25:505-517.
38. Arango C, Calcedo Barba A, Gonzalez-Salvador T, et al. Violence in inpatients with schizophrenia: a prospective study. Schizophr Bull. 1999;25:493-503.
39. Convit A, Volavka J, Czobor P, et al. Effect of subtle neurological dysfunction on response to haloperidol treatment in schizophrenia. Am J Psychiatry. 1994;151:49-56.
40. Sanders RD, McLaughlin N, Pierri JN, et al. Prognostic significance of neurologic examination abnormalities in neuroleptic-naive schizophrenia. J Neuropsychiatry Clin Neurosci. 2000;12:162. Abstract.
41. Galderisi S, Maj M, Mucci A, et al. Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study. Am J Psychiatry. 2002;159:983-990.
42. Buchanan RW, Kirkpatrick B, Heinrichs DW, Carpenter WT Jr. Clinical correlates of the deficit syndrome of schizophrenia. Am J Psychiatry. 1990;147:290-294.
43. Arango C, Kirkpatrick B, Buchanan RW. Neurological signs and the heterogeneity of schizophrenia. Am J Psychiatry. 2000;157: 560-565.
44. Keshavan MS, Narasimha R IV, Narayanan HS. Rate of blinking may predict neuroleptic-induced parkinsonism. Br J Psychiatry. 1983;142:423. Letter.
45. Chatterjee A, Chakos M, Koreen A, et al. Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. Am J Psychiatry. 1995;152:1724-1729.
46. Manschreck TC. Motor and cognitive disturbances in schizophrenic disorders. In: Schulz SC, Tamminga CA, eds. Schizophrenia: Scientific Progress. New York, NY: Oxford University Press; 1989:396-403.
47. Manschreck TC, Keuthen NJ, Schneyer ML, Celada MT, Laughery J, Collins P. Abnormal involuntary movements and chronic schizophrenic disorders. Biol Psychiatry. 1990; 27:150-8.
48. Ismael B, Cantor-Graae E, McNeil TF. Neurodevelopmental origins of tardivelike dyskinesia in schizophrenia patients and their siblings. Schizophr Bull. 2001;27:629-642.
49. Gervin M, Clarke M, Browne S, et al. Spontaneous dyskinesia and neurological soft signs in adolescent onset first episode schizophrenia. Schizophr Res. 2000;43:263. Abstract.
50. Schultz SK, Miller DD, Arndt S, et al. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation. Biol Psychiatry. 1995;38:713-719.